Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novaerus is a medical device and indoor air disinfection company focused on reducing airborne pathogens and improving indoor air quality in healthcare and other indoor environments. The company is best known for its portable air disinfection systems built around its patented NanoStrike technology, which underpins FDA-cleared Class II medical devices. Novaerus products are used in settings such as hospitals, senior living facilities, clinics, schools, and commercial buildings to inactivate airborne viruses, bacteria, mold spores, and other contaminants. Novaerus operates as part of WellAir's broader indoor air quality platform and is marketed as one of WellAir's core brands. Its business is commercial-stage and centered on air disinfection hardware rather than a therapeutic drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novaerus.